CHRIS JULIAM

Barbara holds a PhD in Biomedical Sciences (Ghent University, Belgium) and received training in Conceptual Selling (Miller Heiman) and Digital Transformation (Vlerick Business School, Belgium). In 2020, Barbara was nominated as one of the 50 most inspiring women in Belgian Tech.
She acquired Sales and Marketing, Business Development and Management skills in an international context within companies providing life science services. She was the co-founder and CEO of the healthtech company Akcelis that developed and commercialized tools and services for digital patient recruitment in clinical trials. As a pioneer within Europe, Akcelis became a trusted partner of top 5 pharma and biotech companies managing large international projects across Europe. In 2020, this scale-up was acquired by the Pivotal, a full-services contract research organization for the healthcare industry across Europe. For two years, Barbara was Director Patient Journey at Pivotal before continuing her career as an independent consultant. In May 2022, she joined Vivactis HM3A.